Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep-Oct;48(5):507-517.
doi: 10.1016/j.aller.2020.05.002. Epub 2020 Jul 3.

BCG as a game-changer to prevent the infection and severity of COVID-19 pandemic?

Affiliations
Review

BCG as a game-changer to prevent the infection and severity of COVID-19 pandemic?

A R Sharma et al. Allergol Immunopathol (Madr). 2020 Sep-Oct.

Abstract

The impact of COVID-19 is changing with country wise and depend on universal immunization policies. COVID-19 badly affects countries that did not have universal immunization policies or having them only for the selective population of countries (highly prominent population) like Italy, USA, UK, Netherland, etc. Universal immunization of BCG can provide great protection against the COVID-19 infection because the BCG vaccine gives broad protection against respiratory infections. BCG vaccine induces expressions of the gene that are involved in the antiviral innate immune response against viral infections with long-term maintenance of BCG vaccine-induced cellular immunity. COVID-19 cases are reported very much less in the countries with universal BCG vaccination policies such as India, Afghanistan, Nepal, Bhutan, Bangladesh, Israel, Japan, etc. as compared to without BCG implemented countries such as the USA, Italy, Spain, Canada, UK, etc. BCG vaccine provides protection for 50-60 years of immunization, so the elderly population needs to be revaccinated with BCG. Several countries started clinical trials of the BCG vaccine for health care workers and elderly people. BCG can be uses as a prophylactic treatment until the availability of the COVID-19 vaccine.

Keywords: Antigen specific immunity; BCG; COVID-19; HCW; Immune response; Revaccination.

PubMed Disclaimer

Comment in

Similar articles

Cited by

References

    1. COVID-19 coronavirus pandemic. https://www.worldometers.info/coronavirus/ (accessed 27 April 2020).
    1. de Wit E., van Doremalen N., Falzarano D., Munster V.J. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14 - PMC - PubMed
    1. Chan J.F., Yuan S., Kok K.H., To K.K., Chu H., Yang J., et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020:30154–30159. doi: 10.1016/s0140-6736(20). - DOI - PMC - PubMed
    1. Otter J.A., Donskey C., Yezli S., Douthwaite S., Goldenberg S.D., Weber D.J. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J Hosp Infect. 2016;92 - PMC - PubMed
    1. Dowell S.F., Simmerman J.M., Erdman D.D., Wu J.S., Chaovavanich A., Javadi M., et al. Severe acute respiratory syndrome coronavirus on hospital surfaces. Clin Infect Dis. 2004;39 652e7. - PMC - PubMed

MeSH terms